Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical reported $-154105000 in EBIT for its fiscal quarter ending in March of 2023.

Ebit Change
Acadia Pharmaceuticals ACAD:US USD -53584000 7.52M
Agios Pharmaceuticals AGIO:US USD -90613000 8.56M
Alnylam Pharmaceuticals ALNY:US USD -149807000 38.81M
BioCryst Pharmaceuticals BCRX:US USD -28415000 17.9M
BioMarin Pharmaceutical BMRN:US USD 61.45M 85.95M
Bluebird Bio BLUE:US USD -84493000 7.93M
Esperion Therapeutics ESPR:US USD -48605000 6.09M
Immunic Inc. VTL:US USD -27251000 2.89M
Insmed INSM:US USD -157658000 4.38M
Ionis Pharmaceuticals IONS:US USD -114148000 93.87M
Karyopharm Therapeutics KPTI:US USD -30899000 2.97M
Kyowa Hakko Kirin 4151:JP JPY 13.82B 7.78B
MacroGenics MGNX:US USD -38426000 50.41M
Mirati Therapeutics MRTX:US USD -193823000 17.9M
Moderna Inc MRNA:US USD -366000000 1.95B
Neurocrine Biosciences NBIX:US USD 29.7M 73.7M
PTC Therapeutics PTCT:US USD -117615000 49.34M
Puma Biotechnology PBYI:US USD 4.36M 5.65M
Regeneron Pharmaceuticals REGN:US USD 1B 174M
Sarepta Therapeutics SRPT:US USD -138088000 31.26M
Ultragenyx Pharmaceutical RARE:US USD -154105000 8.48M
Vertex Pharmaceuticals VRTX:US USD 779M 254.5M
Xoma XOMA:US USD -10170000 3.96M